SCHEMBL6398018

SCHEMBL6398018

O=P(O)(O)c1cc(O)cc(O)c1CCCCc1cccc(O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.47
HDAC6 Q9UBN7 1/20 0.46
SLC28A3 Q9HAS3 1/20 0.44
DRD2 P14416 1/20 0.42
DRD1 P21728 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
CALM1 P0DP23 1/20 0.40
CBS P35520 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
OPRK1 P41145 1/20 0.39
HTR7 P34969 1/20 0.39
TYR P14679 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404256 0.97 SLC28A3 (0.47) MGLLHDAC6SLC28A3DRD2DRD1
SCHEMBL6397173 0.91 DRD2 (0.45) MGLLDRD2DRD1TAAR1CALM1
SCHEMBL6403912 0.89 MGLL (0.47) MGLLHDAC6DRD2DRD1TAAR1
SCHEMBL6397457 0.86 MGLL (0.43) MGLLHDAC6SLC28A3DRD2DRD1
SCHEMBL6397728 0.85 SLC28A3 (0.63) MGLLSLC28A3CBSCHRM2CHRM1
SCHEMBL6395084 0.82 SLC28A3 (0.68) SLC28A3CALM1CHRM2CHRM1CHRM3
SCHEMBL6395755 0.81 MGLL (0.48) MGLLHDAC6DRD2DRD1TAAR1
SCHEMBL6397103 0.80 CBS (0.53) MGLLHDAC6SLC28A3DRD2DRD1
SCHEMBL6396016 0.80 MGLL (0.39) MGLLHDAC6DRD2DRD1TAAR1
SCHEMBL28285028 0.80 SLC28A3 (0.67) MGLLHDAC6SLC28A3DRD2DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans PEERCE BRIAN E (US) 2005-08-25 US disclosed
US-6787528-B2 THERAPY FOR KIDNEY DISEASES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2004-09-07 US disclosed
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-08-28 US disclosed
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation PEERCE BRIAN E (US) 2002-09-19 US disclosed
US-6355823-B1 MEMBRANE SUBSTRATE PHOSPHATED FOR DRUGS FOR GASTROINTESTINAL DISORDERS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2002-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 MGLL 3457/4885HDAC6 4653/4885SLC28A3 48/4885
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation SLC10A2, SLC34A3, SLC34A1 MGLL 3439/4885HDAC6 4532/4885SLC28A3 47/4885
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 MGLL 3457/4885HDAC6 4653/4885SLC28A3 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.